Nuzenio

Revolution Medicines Reports

Revolution Medicines Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Why Revolution Medicines (RVMD) Is Up 9.4% After Mounting Losses And Surging Daraxonrasib Demand – And What's Next - simplywall.stsimplywall.st · Sat, 08 Aug 2026 19:45:53 GMT Sei Investments Co. Cuts Holdings in Revolution Medicines, Inc. $RVMD - MarketBeatMarketBeat · Sat, 08 Aug 2026 09:19:54 GMT Revolution Medicines, Inc. (RVMD) interactive stock chart - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 16:02:50 GMT RVMD Posts Wider-Than-Anticipated Loss in Q2, Lifts '26 Expense View - TradingViewTradingView · Thu, 06 Aug 2026 18:00:00 GMT Guggenheim raises Revolution stock price target to $240 on pipeline progress - Investing.comInvesting.com · Thu, 06 Aug 2026 12:32:00 GMT Needham & Company LLC Raises Revolution Medicines (NASDAQ:RVMD) Price Target to $240.00 - MarketBeatMarketBeat · Thu, 06 Aug 2026 12:10:36 GMT Quantinno Capital Management LP Boosts Stake in Revolution Medicines, Inc. $RVMD - MarketBeatMarketBeat · Thu, 06 Aug 2026 08:47:33 GMT Revolution Medicines Q2 Earnings Call Highlights - MarketBeatMarketBeat · Thu, 06 Aug 2026 04:08:24 GMT

Timeline

Sat, 08 Aug 2026 19:45:53 GMTWhy Revolution Medicines (RVMD) Is Up 9.4% After Mounting Losses And Surging Daraxonrasib Demand – And What's Next - simplywall.st

Sat, 08 Aug 2026 09:19:54 GMTSei Investments Co. Cuts Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat

Fri, 07 Aug 2026 16:02:50 GMTRevolution Medicines, Inc. (RVMD) interactive stock chart - Yahoo Finance Singapore

Thu, 06 Aug 2026 18:00:00 GMTRVMD Posts Wider-Than-Anticipated Loss in Q2, Lifts '26 Expense View - TradingView

Thu, 06 Aug 2026 12:32:00 GMTGuggenheim raises Revolution stock price target to $240 on pipeline progress - Investing.com

Thu, 06 Aug 2026 12:10:36 GMTNeedham & Company LLC Raises Revolution Medicines (NASDAQ:RVMD) Price Target to $240.00 - MarketBeat

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Revolution Medicines30 live mentions RVMD23 live mentions Inc22 live mentions NASDAQ10 live mentions RVMD MarketBeat MarketBeat7 live mentions MarketBeat MarketBeat4 live mentions MarketBeat Revolution Medicines4 live mentions Shares4 live mentions Yahoo Finance Singapore3 live mentions Investing3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Revolution Medicines Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.